Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
7.40
0.28 (3.93%)
At close: Aug 15, 2025, 3:59 PM
7.40
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Amicus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.11M -151.58M -236.57M -250.46M
Depreciation & Amortization
8.55M 7.87M 5.34M 6.21M
Stock-Based Compensation
84.91M 86.08M 76.51M 57.84M
Other Working Capital
10.71M -32.46M -10.83M -10.04M
Other Non-Cash Items
-71.24M 41.47M 28.01M 2.47M
Deferred Income Tax
n/a -4.94M 9K 34K
Change in Working Capital
n/a -47.99M -39.88M -18.59M
Operating Cash Flow
-33.89M -69.09M -166.57M -202.49M
Capital Expenditures
-3.55M -7.44M -3.77M -3.88M
Cash Acquisitions
n/a n/a 3.41M 3.88M
Purchase of Investments
-114.79M -91.72M -243.25M -341.4M
Sales Maturities Of Investments
117.78M 197.23M 335.93M 424.04M
Other Investing Acitivies
n/a n/a 3.41M -3.88M
Investing Cash Flow
-560K 98.06M 92.32M 78.76M
Debt Repayment
-97K -20.96M -283K -479K
Common Stock Repurchased
n/a n/a -11.49M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.22M -20.57M n/a 12.8M
Financial Cash Flow
5.12M 61.68M -7.46M 212.07M
Net Cash Flow
-33.36M 96.96M -96.34M 83.29M
Free Cash Flow
-37.44M -76.53M -170.34M -206.38M